The present invention relates to novel compounds which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
本发明涉及一种新的化合物,能够调节B-raf激酶,并将这种化合物用于治疗各种疾病,障碍或病况。
Type II raf kinase inhibitors
申请人:Dana-Farber Cancer Institute, Inc.
公开号:EP2937345A2
公开(公告)日:2015-10-28
The present invention relates to novel compounds (II), (III) and (IV) which are able to modulate b-raf kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.